Under construction – not a live service
Sign in
Not yet taking people in IsraelNo phase

How People With Parkinson's Disease Judge Stepping Over Obstacles

Compares how older adults with and without Parkinson's disease judge crossing an obstacle.

Plain-language title generated from the registry record
Registry title: Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease

Key facts

Where
Haifa, IsraelSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 65 and 85 years old?

Source: NCT07907770, who can take part

Where in Israel

  • University of HaifaHaifa, IsraelNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Haifa
Trial code
NCT07907770
Record updated
30 October 2026
Original description
The study examines how individuals with Parkinson's disease, compared to healthy older adults, evaluate their ability to cross an obstacle, and the association between this evaluation, motor and cognitive status, and self-awareness.Read full original descriptionShow less

Perception of Action Opportunities for Obstacle Crossing in Individuals With Parkinson's Disease: Associations With Motor and Cognitive Impairments and Self-Awareness

The study examines how individuals with Parkinson's disease, compared to healthy older adults, evaluate their ability to cross an obstacle, and the association between this evaluation, motor and cognitive status, and self-awareness.

A total of 120 participants aged 65-85 years will be recruited: 60 with Parkinson's disease and 60 healthy adults. Following a telephone screening, eligible participants will be invited to a single session lasting 1.5 to 2 hours at the University of Haifa, a Maccabi Healthcare Services institute, or the participant's home.

During the session, following an explanation and the signing of an informed consent form, demographic and clinical data will be collected, anthropometric measurements will be taken, and questionnaires addressing walking confidence and emotional state will be completed. Furthermore, mobility will be assessed using the Timed Up and Go test, motor symptom severity will be assessed using the UPDRS-III (for individuals with Parkinson's disease only), and cognitive function will be evaluated via a computerized test. Finally, participants will perform the research task. In this task, while standing in front of the obstacle, they will be asked to estimate the maximum obstacle height they believe they can safely cross. Following this, they will be asked to actually cross it. Based on these data, the gap between perceived and actual ability will be calculated. The task will be performed under two conditions: without a backpack and with a weighted backpack (carrying approximately 10% of the participant's body weight). The performance of the research task will be video-recorded for the analysis of crossing data.

Inclusion: Diagnosis of Parkinson's disease according to medical records; Ability to walk independently outdoors without walking aids in daily life; Fluent in reading and speaking Hebrew; Ability to walk independently outdoors without walking aids in daily life; Fluent in reading and speaking Hebrew; No diagnosis of Parkinson's disease or any other neurological condition.

Exclusion: Severe visual impairment that cannot be corrected with glasses (self-report); Dementia (Telephone Mini-Mental State Examination score ≤ 18); Any orthopaedic condition, pain, or health condition (other than PD) that affects walking (self-report); Freezing of gait (Score > 0 on the NFOG-Q), for PD group only.

ClinicalTrials.gov NCT07907770